A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
Clinical trial NCT01703312 · COMPLETED
Trial details
- NCT number
- NCT01703312
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-10-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.